0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urogynecologic Surgical Mesh Implants Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-31S17090
Home | Market Reports | Beauty & Fitness| Cosmetic Procedures
Global Urogynecologic Surgical Mesh Implants Market Research Report 2024
BUY CHAPTERS

Global Urogynecologic Surgical Mesh Implants Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31S17090
Report
November 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Urogynecologic Surgical Mesh Implants Market

The global Urogynecologic Surgical Mesh Implants market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hernia Repair accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Urogynecologic Surgical Mesh Implants leading manufacturers including Gore & Associates, Boston Scientific, Mölnlycke Health Care, TEPHA, Medtronic, LifeCell International, B. Braun Melsungen, Betatech Medical, Johnson & Johnson, C.R. Bard, etc., dominate supply; the top five capture approximately % of global revenue, with Gore & Associates leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Urogynecologic Surgical Mesh Implants market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Urogynecologic Surgical Mesh Implants Market Report

Report Metric Details
Report Name Urogynecologic Surgical Mesh Implants Market
Segment by Type
  • Absorbable Implant
  • Non-absorbable Implant
Segment by Application
  • Hernia Repair
  • Trauma or Surgical Wound
  • Abdominal Wall Reconstruction
  • Facial Surgery
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gore & Associates, Boston Scientific, Mölnlycke Health Care, TEPHA, Medtronic, LifeCell International, B. Braun Melsungen, Betatech Medical, Johnson & Johnson, C.R. Bard
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Urogynecologic Surgical Mesh Implants study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Urogynecologic Surgical Mesh Implants Market report?

Ans: The main players in the Urogynecologic Surgical Mesh Implants Market are Gore & Associates, Boston Scientific, Mölnlycke Health Care, TEPHA, Medtronic, LifeCell International, B. Braun Melsungen, Betatech Medical, Johnson & Johnson, C.R. Bard

What are the Application segmentation covered in the Urogynecologic Surgical Mesh Implants Market report?

Ans: The Applications covered in the Urogynecologic Surgical Mesh Implants Market report are Hernia Repair, Trauma or Surgical Wound, Abdominal Wall Reconstruction, Facial Surgery, Other

What are the Type segmentation covered in the Urogynecologic Surgical Mesh Implants Market report?

Ans: The Types covered in the Urogynecologic Surgical Mesh Implants Market report are Absorbable Implant, Non-absorbable Implant

1 Study Coverage
1.1 Introduction to Urogynecologic Surgical Mesh Implants: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Urogynecologic Surgical Mesh Implants Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Absorbable Implant
1.2.3 Non-absorbable Implant
1.3 Market Segmentation by Application
1.3.1 Global Urogynecologic Surgical Mesh Implants Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hernia Repair
1.3.3 Trauma or Surgical Wound
1.3.4 Abdominal Wall Reconstruction
1.3.5 Facial Surgery
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urogynecologic Surgical Mesh Implants Revenue Estimates and Forecasts 2020-2031
2.2 Global Urogynecologic Surgical Mesh Implants Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Urogynecologic Surgical Mesh Implants Sales Estimates and Forecasts 2020-2031
2.4 Global Urogynecologic Surgical Mesh Implants Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Urogynecologic Surgical Mesh Implants Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Urogynecologic Surgical Mesh Implants Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Absorbable Implant Market Size by Manufacturers
3.5.2 Non-absorbable Implant Market Size by Manufacturers
3.6 Global Urogynecologic Surgical Mesh Implants Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Urogynecologic Surgical Mesh Implants Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Urogynecologic Surgical Mesh Implants Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Urogynecologic Surgical Mesh Implants Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Urogynecologic Surgical Mesh Implants Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Urogynecologic Surgical Mesh Implants Sales and Revenue by Type (2020-2031)
6.4 North America Urogynecologic Surgical Mesh Implants Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Urogynecologic Surgical Mesh Implants Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Urogynecologic Surgical Mesh Implants Sales and Revenue by Type (2020-2031)
7.4 Europe Urogynecologic Surgical Mesh Implants Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Urogynecologic Surgical Mesh Implants Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Urogynecologic Surgical Mesh Implants Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Urogynecologic Surgical Mesh Implants Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Urogynecologic Surgical Mesh Implants Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Urogynecologic Surgical Mesh Implants Sales and Revenue by Type (2020-2031)
9.4 Central and South America Urogynecologic Surgical Mesh Implants Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Urogynecologic Surgical Mesh Implants Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Urogynecologic Surgical Mesh Implants Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Urogynecologic Surgical Mesh Implants Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Urogynecologic Surgical Mesh Implants Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gore & Associates
11.1.1 Gore & Associates Corporation Information
11.1.2 Gore & Associates Business Overview
11.1.3 Gore & Associates Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.1.4 Gore & Associates Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gore & Associates Urogynecologic Surgical Mesh Implants Sales by Product in 2024
11.1.6 Gore & Associates Urogynecologic Surgical Mesh Implants Sales by Application in 2024
11.1.7 Gore & Associates Urogynecologic Surgical Mesh Implants Sales by Geographic Area in 2024
11.1.8 Gore & Associates Urogynecologic Surgical Mesh Implants SWOT Analysis
11.1.9 Gore & Associates Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.2.4 Boston Scientific Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Boston Scientific Urogynecologic Surgical Mesh Implants Sales by Product in 2024
11.2.6 Boston Scientific Urogynecologic Surgical Mesh Implants Sales by Application in 2024
11.2.7 Boston Scientific Urogynecologic Surgical Mesh Implants Sales by Geographic Area in 2024
11.2.8 Boston Scientific Urogynecologic Surgical Mesh Implants SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 Mölnlycke Health Care
11.3.1 Mölnlycke Health Care Corporation Information
11.3.2 Mölnlycke Health Care Business Overview
11.3.3 Mölnlycke Health Care Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.3.4 Mölnlycke Health Care Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Mölnlycke Health Care Urogynecologic Surgical Mesh Implants Sales by Product in 2024
11.3.6 Mölnlycke Health Care Urogynecologic Surgical Mesh Implants Sales by Application in 2024
11.3.7 Mölnlycke Health Care Urogynecologic Surgical Mesh Implants Sales by Geographic Area in 2024
11.3.8 Mölnlycke Health Care Urogynecologic Surgical Mesh Implants SWOT Analysis
11.3.9 Mölnlycke Health Care Recent Developments
11.4 TEPHA
11.4.1 TEPHA Corporation Information
11.4.2 TEPHA Business Overview
11.4.3 TEPHA Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.4.4 TEPHA Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 TEPHA Urogynecologic Surgical Mesh Implants Sales by Product in 2024
11.4.6 TEPHA Urogynecologic Surgical Mesh Implants Sales by Application in 2024
11.4.7 TEPHA Urogynecologic Surgical Mesh Implants Sales by Geographic Area in 2024
11.4.8 TEPHA Urogynecologic Surgical Mesh Implants SWOT Analysis
11.4.9 TEPHA Recent Developments
11.5 Medtronic
11.5.1 Medtronic Corporation Information
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.5.4 Medtronic Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Medtronic Urogynecologic Surgical Mesh Implants Sales by Product in 2024
11.5.6 Medtronic Urogynecologic Surgical Mesh Implants Sales by Application in 2024
11.5.7 Medtronic Urogynecologic Surgical Mesh Implants Sales by Geographic Area in 2024
11.5.8 Medtronic Urogynecologic Surgical Mesh Implants SWOT Analysis
11.5.9 Medtronic Recent Developments
11.6 LifeCell International
11.6.1 LifeCell International Corporation Information
11.6.2 LifeCell International Business Overview
11.6.3 LifeCell International Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.6.4 LifeCell International Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 LifeCell International Recent Developments
11.7 B. Braun Melsungen
11.7.1 B. Braun Melsungen Corporation Information
11.7.2 B. Braun Melsungen Business Overview
11.7.3 B. Braun Melsungen Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.7.4 B. Braun Melsungen Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 B. Braun Melsungen Recent Developments
11.8 Betatech Medical
11.8.1 Betatech Medical Corporation Information
11.8.2 Betatech Medical Business Overview
11.8.3 Betatech Medical Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.8.4 Betatech Medical Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Betatech Medical Recent Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.9.4 Johnson & Johnson Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Johnson & Johnson Recent Developments
11.10 C.R. Bard
11.10.1 C.R. Bard Corporation Information
11.10.2 C.R. Bard Business Overview
11.10.3 C.R. Bard Urogynecologic Surgical Mesh Implants Product Models, Descriptions and Specifications
11.10.4 C.R. Bard Urogynecologic Surgical Mesh Implants Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 C.R. Bard Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Urogynecologic Surgical Mesh Implants Industry Chain
12.2 Urogynecologic Surgical Mesh Implants Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Urogynecologic Surgical Mesh Implants Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Urogynecologic Surgical Mesh Implants Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Urogynecologic Surgical Mesh Implants Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Urogynecologic Surgical Mesh Implants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Urogynecologic Surgical Mesh Implants Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Urogynecologic Surgical Mesh Implants Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Urogynecologic Surgical Mesh Implants Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Urogynecologic Surgical Mesh Implants Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Urogynecologic Surgical Mesh Implants Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Urogynecologic Surgical Mesh Implants Sales by Region (2020-2025) & (K Units)
 Table 8. Global Urogynecologic Surgical Mesh Implants Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Urogynecologic Surgical Mesh Implants Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Urogynecologic Surgical Mesh Implants Sales Share by Manufacturers (2020-2025)
 Table 12. Global Urogynecologic Surgical Mesh Implants Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Urogynecologic Surgical Mesh Implants Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Urogynecologic Surgical Mesh Implants by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urogynecologic Surgical Mesh Implants as of 2024)
 Table 16. Global Urogynecologic Surgical Mesh Implants Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Urogynecologic Surgical Mesh Implants Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Urogynecologic Surgical Mesh Implants Manufacturing Base and Headquarters
 Table 19. Global Urogynecologic Surgical Mesh Implants Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Urogynecologic Surgical Mesh Implants Sales by Type (2020-2025) & (K Units)
 Table 23. Global Urogynecologic Surgical Mesh Implants Sales by Type (2026-2031) & (K Units)
 Table 24. Global Urogynecologic Surgical Mesh Implants Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Urogynecologic Surgical Mesh Implants Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Urogynecologic Surgical Mesh Implants ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Urogynecologic Surgical Mesh Implants Sales by Application (2020-2025) & (K Units)
 Table 29. Global Urogynecologic Surgical Mesh Implants Sales by Application (2026-2031) & (K Units)
 Table 30. Urogynecologic Surgical Mesh Implants High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Urogynecologic Surgical Mesh Implants Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Urogynecologic Surgical Mesh Implants Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Urogynecologic Surgical Mesh Implants ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Urogynecologic Surgical Mesh Implants Growth Accelerators and Market Barriers
 Table 37. North America Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Urogynecologic Surgical Mesh Implants Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Urogynecologic Surgical Mesh Implants Growth Accelerators and Market Barriers
 Table 40. Europe Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Urogynecologic Surgical Mesh Implants Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Urogynecologic Surgical Mesh Implants Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Urogynecologic Surgical Mesh Implants Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Urogynecologic Surgical Mesh Implants Investment Opportunities and Key Challenges
 Table 47. Central and South America Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Urogynecologic Surgical Mesh Implants Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Urogynecologic Surgical Mesh Implants Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Gore & Associates Corporation Information
 Table 51. Gore & Associates Description and Major Businesses
 Table 52. Gore & Associates Product Models, Descriptions and Specifications
 Table 53. Gore & Associates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Gore & Associates Sales Value Proportion by Product in 2024
 Table 55. Gore & Associates Sales Value Proportion by Application in 2024
 Table 56. Gore & Associates Sales Value Proportion by Geographic Area in 2024
 Table 57. Gore & Associates Urogynecologic Surgical Mesh Implants SWOT Analysis
 Table 58. Gore & Associates Recent Developments
 Table 59. Boston Scientific Corporation Information
 Table 60. Boston Scientific Description and Major Businesses
 Table 61. Boston Scientific Product Models, Descriptions and Specifications
 Table 62. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Boston Scientific Sales Value Proportion by Product in 2024
 Table 64. Boston Scientific Sales Value Proportion by Application in 2024
 Table 65. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 66. Boston Scientific Urogynecologic Surgical Mesh Implants SWOT Analysis
 Table 67. Boston Scientific Recent Developments
 Table 68. Mölnlycke Health Care Corporation Information
 Table 69. Mölnlycke Health Care Description and Major Businesses
 Table 70. Mölnlycke Health Care Product Models, Descriptions and Specifications
 Table 71. Mölnlycke Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Mölnlycke Health Care Sales Value Proportion by Product in 2024
 Table 73. Mölnlycke Health Care Sales Value Proportion by Application in 2024
 Table 74. Mölnlycke Health Care Sales Value Proportion by Geographic Area in 2024
 Table 75. Mölnlycke Health Care Urogynecologic Surgical Mesh Implants SWOT Analysis
 Table 76. Mölnlycke Health Care Recent Developments
 Table 77. TEPHA Corporation Information
 Table 78. TEPHA Description and Major Businesses
 Table 79. TEPHA Product Models, Descriptions and Specifications
 Table 80. TEPHA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. TEPHA Sales Value Proportion by Product in 2024
 Table 82. TEPHA Sales Value Proportion by Application in 2024
 Table 83. TEPHA Sales Value Proportion by Geographic Area in 2024
 Table 84. TEPHA Urogynecologic Surgical Mesh Implants SWOT Analysis
 Table 85. TEPHA Recent Developments
 Table 86. Medtronic Corporation Information
 Table 87. Medtronic Description and Major Businesses
 Table 88. Medtronic Product Models, Descriptions and Specifications
 Table 89. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Medtronic Sales Value Proportion by Product in 2024
 Table 91. Medtronic Sales Value Proportion by Application in 2024
 Table 92. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 93. Medtronic Urogynecologic Surgical Mesh Implants SWOT Analysis
 Table 94. Medtronic Recent Developments
 Table 95. LifeCell International Corporation Information
 Table 96. LifeCell International Description and Major Businesses
 Table 97. LifeCell International Product Models, Descriptions and Specifications
 Table 98. LifeCell International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. LifeCell International Recent Developments
 Table 100. B. Braun Melsungen Corporation Information
 Table 101. B. Braun Melsungen Description and Major Businesses
 Table 102. B. Braun Melsungen Product Models, Descriptions and Specifications
 Table 103. B. Braun Melsungen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. B. Braun Melsungen Recent Developments
 Table 105. Betatech Medical Corporation Information
 Table 106. Betatech Medical Description and Major Businesses
 Table 107. Betatech Medical Product Models, Descriptions and Specifications
 Table 108. Betatech Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Betatech Medical Recent Developments
 Table 110. Johnson & Johnson Corporation Information
 Table 111. Johnson & Johnson Description and Major Businesses
 Table 112. Johnson & Johnson Product Models, Descriptions and Specifications
 Table 113. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Johnson & Johnson Recent Developments
 Table 115. C.R. Bard Corporation Information
 Table 116. C.R. Bard Description and Major Businesses
 Table 117. C.R. Bard Product Models, Descriptions and Specifications
 Table 118. C.R. Bard Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. C.R. Bard Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Urogynecologic Surgical Mesh Implants Product Picture
 Figure 2. Global Urogynecologic Surgical Mesh Implants Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Absorbable Implant Product Picture
 Figure 4. Non-absorbable Implant Product Picture
 Figure 5. Global Urogynecologic Surgical Mesh Implants Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hernia Repair
 Figure 7. Trauma or Surgical Wound
 Figure 8. Abdominal Wall Reconstruction
 Figure 9. Facial Surgery
 Figure 10. Other
 Figure 11. Urogynecologic Surgical Mesh Implants Report Years Considered
 Figure 12. Global Urogynecologic Surgical Mesh Implants Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Urogynecologic Surgical Mesh Implants Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Urogynecologic Surgical Mesh Implants Revenue Market Share by Region (2020-2031)
 Figure 16. Global Urogynecologic Surgical Mesh Implants Sales (2020-2031) & (K Units)
 Figure 17. Global Urogynecologic Surgical Mesh Implants Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global Urogynecologic Surgical Mesh Implants Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Urogynecologic Surgical Mesh Implants Sales Volume Market Share in 2024
 Figure 20. Global Urogynecologic Surgical Mesh Implants Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Absorbable Implant Revenue Market Share by Manufacturer in 2024
 Figure 23. Non-absorbable Implant Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Urogynecologic Surgical Mesh Implants Sales Market Share by Type (2020-2031)
 Figure 25. Global Urogynecologic Surgical Mesh Implants Revenue Market Share by Type (2020-2031)
 Figure 26. Global Urogynecologic Surgical Mesh Implants Sales Market Share by Application (2020-2031)
 Figure 27. Global Urogynecologic Surgical Mesh Implants Revenue Market Share by Application (2020-2031)
 Figure 28. North America Urogynecologic Surgical Mesh Implants Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Urogynecologic Surgical Mesh Implants Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) in 2024
 Figure 31. North America Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Urogynecologic Surgical Mesh Implants Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Urogynecologic Surgical Mesh Implants Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 46. France Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Urogynecologic Surgical Mesh Implants Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Urogynecologic Surgical Mesh Implants Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 61. India Urogynecologic Surgical Mesh Implants Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Urogynecologic Surgical Mesh Implants Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Urogynecologic Surgical Mesh Implants Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Urogynecologic Surgical Mesh Implants Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Urogynecologic Surgical Mesh Implants Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Urogynecologic Surgical Mesh Implants Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Urogynecologic Surgical Mesh Implants Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Urogynecologic Surgical Mesh Implants Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Urogynecologic Surgical Mesh Implants Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Urogynecologic Surgical Mesh Implants Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Urogynecologic Surgical Mesh Implants Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Urogynecologic Surgical Mesh Implants Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Urogynecologic Surgical Mesh Implants Revenue (2020-2025) & (US$ Million)
 Figure 82. Urogynecologic Surgical Mesh Implants Industry Chain Mapping
 Figure 83. Regional Urogynecologic Surgical Mesh Implants Manufacturing Base Distribution (%)
 Figure 84. Global Urogynecologic Surgical Mesh Implants Production Market Share by Region (2020-2031)
 Figure 85. Urogynecologic Surgical Mesh Implants Production Process
 Figure 86. Regional Urogynecologic Surgical Mesh Implants Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure